4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide

C27H33N7O2 — CID 138715410

IUPAC4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide
SMILESCNc1cc2c(cn1)c(-c1cnn(C)c1)nn2C1CCC(Oc2ccc(C(=O)NC(C)C)cc2)CC1
InChIInChI=1S/C27H33N7O2/c1-17(2)31-27(35)18-5-9-21(10-6-18)36-22-11-7-20(8-12-22)34-24-13-25(28-3)29-15-23(24)26(32-34)19-14-30-33(4)16-19/h5-6,9-10,13-17,20,22H,7-8,11-12H2,1-4H3,(H,28,29)(H,31,35)
InChIKeyFEMNETXMVKEMJZ-UHFFFAOYSA-N
MW487.61 g/mol
LogP4.57
Rot. Bonds7

About 4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide

4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide (PubChem CID 138715410) has the molecular formula C27H33N7O2 and a molecular weight of 487.61 g/mol. Its IUPAC name is 4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide.

Molecular Properties

Compound Name4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide
PubChem CID138715410
Molecular FormulaC27H33N7O2
Molecular Weight487.61 g/mol
Exact Mass487.27
IUPAC Name4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide
SMILESCNc1cc2c(cn1)c(-c1cnn(C)c1)nn2C1CCC(Oc2ccc(C(=O)NC(C)C)cc2)CC1
InChIInChI=1S/C27H33N7O2/c1-17(2)31-27(35)18-5-9-21(10-6-18)36-22-11-7-20(8-12-22)34-24-13-25(28-3)29-15-23(24)26(32-34)19-14-30-33(4)16-19/h5-6,9-10,13-17,20,22H,7-8,11-12H2,1-4H3,(H,28,29)(H,31,35)
InChIKeyFEMNETXMVKEMJZ-UHFFFAOYSA-N
XLogP4.57
TPSA98.89 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms36
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500487.61
LogP ≤ 54.57
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze 4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide?
The IUPAC name of 4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide (CID 138715410) is 4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide.
What is the SMILES notation for 4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide?
The canonical SMILES for 4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide is CNc1cc2c(cn1)c(-c1cnn(C)c1)nn2C1CCC(Oc2ccc(C(=O)NC(C)C)cc2)CC1.
What is the InChIKey of 4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide?
The InChIKey is FEMNETXMVKEMJZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H33N7O2/c1-17(2)31-27(35)18-5-9-21(10-6-18)36-22-11-7-20(8-12-22)34-24-13-25(28-3)29-15-23(24)26(32-34)19-14-30-33(4)16-19/h5-6,9-10,13-17,20,22H,7-8,11-12H2,1-4H3,(H,28,29)(H,31,35).
What are the key properties of 4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide?
4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide has a molecular weight of 487.61 g/mol, XLogP of 4.57, 7 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-[6-(methylamino)-3-(1-methylpyrazol-4-yl)pyrazolo[4,3-c]pyridin-1-yl]cyclohexyl]oxy-N-propan-2-ylbenzamide is sourced from PubChem (CID 138715410), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).